516 related articles for article (PubMed ID: 26680379)
1. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.
MacDonald MH; Zhang G; Tasse L; Wang D; De Leon H; Kocharian R
J Mater Sci Mater Med; 2021 Sep; 32(10):127. PubMed ID: 34591193
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo.
Landi A; Gregori F; Marotta N; Delfini R
J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):139-43. PubMed ID: 26351870
[TBL] [Abstract][Full Text] [Related]
4. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
5. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery.
Woodworth BA; Chandra RK; LeBenger JD; Ilie B; Schlosser RJ
Am J Otolaryngol; 2009; 30(1):49-53. PubMed ID: 19027513
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
7. An Efficacy Comparison of Two Hemostatic Agents in a Porcine Liver Bleeding Model: Gelatin/Thrombin Flowable Matrix versus Collagen/Thrombin Powder.
Slezak P; Keibl C; Redl H; Labahn D; Gulle H
J Invest Surg; 2020 Oct; 33(9):828-838. PubMed ID: 30907197
[No Abstract] [Full Text] [Related]
8. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
9. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
Makhija D; Rock M; Ikeme S; Kuntze E; Epstein JD; Nicholson G; Price JS; Patel V
J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
[TBL] [Abstract][Full Text] [Related]
10. Gelatin Paste as an Alternative Cost-Effective Hemostatic Agent in Cranial Surgery: Doing More with Less.
Serrato-Avila JL; Navarro-Fernández JO; Hernández-Reséndiz R; Cacho-Díaz B; Reyes-Soto G; Monroy-Sosa A
World Neurosurg; 2019 Feb; 122():224-228. PubMed ID: 30415038
[TBL] [Abstract][Full Text] [Related]
11. Comparison the efficacy of hemorrhage control of Surgiflo Haemostatic Matrix and absorbable gelatin sponge in posterior lumbar surgery: A randomized controlled study.
Ma L; Dai L; Yang Y; Liu H
Medicine (Baltimore); 2018 Dec; 97(49):e13511. PubMed ID: 30544449
[TBL] [Abstract][Full Text] [Related]
12. Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery.
Gazzeri R; Galarza M; Conti C; De Bonis C
Neurosurg Rev; 2018 Jan; 41(1):303-310. PubMed ID: 28439721
[TBL] [Abstract][Full Text] [Related]
13. Use of floseal hemostatic matrix for control of hemostasis during laparoscopic cholecystectomy for acute cholecystitis: a multicenter historical control group comparison (the GLA study gelatin matrix for acute cholecystitis).
Sartelli M; Catena F; Biancafarina A; Tranà C; Piccardo A; Ceccarelli G; Tirone G; Agresta F; Di Giorgio A; Catani M; Tricarico F; Buonanno M; Piazza L
J Laparoendosc Adv Surg Tech A; 2014 Dec; 24(12):837-41. PubMed ID: 25025393
[TBL] [Abstract][Full Text] [Related]
14. Real-world outcomes of hemostatic matrices in cardiac surgery.
Tackett SM; Calcaterra D; Magee G; Lattouf OM
J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1558-65. PubMed ID: 25245578
[TBL] [Abstract][Full Text] [Related]
15. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
Gazzeri R; Galarza M; Alfier A
Surg Technol Int; 2012 Dec; 22():49-54. PubMed ID: 22915500
[TBL] [Abstract][Full Text] [Related]
16. Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study.
Obermair H; Janda M; Obermair A
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):1008-14. PubMed ID: 27199208
[TBL] [Abstract][Full Text] [Related]
17. Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix.
Pursifull NF; Morris MS; Harris RA; Morey AF
J Trauma; 2006 Feb; 60(2):346-50. PubMed ID: 16508494
[TBL] [Abstract][Full Text] [Related]
18. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery.
Price JS; Tackett S; Patel V
J Med Econ; 2015; 18(10):777-86. PubMed ID: 25934148
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Topical Hemostatic Agents: A Comparative Evaluation of Two Gelatin/Thrombin-Based Hemostatic Matrices in a Porcine Kidney Surgical Model.
Slezak P; Heher P; Monforte X; Keibl C; Redl H; Spazierer D; Gulle H
J Invest Surg; 2019 Nov; 32(7):646-653. PubMed ID: 29561208
[No Abstract] [Full Text] [Related]
20. What happens to hemostatic agents in contact with urine? An in vitro study.
Uribe CA; Eichel L; Khonsari S; Finley DS; Basillote J; Park HK; Li CC; Abdelshehid C; Lee DI; McDougall EM; Clayman RV
J Endourol; 2005 Apr; 19(3):312-7. PubMed ID: 15865520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
